Home NDC 64760-408 Glytone Body
Product NDC 64760-408
11-digit product format 647600408
Labeler code 64760
Product ID 64760-408_0e45b33d-ff71-4c2c-80d3-75687c31b43f
Type HUMAN OTC DRUG
Nonproprietary name Octinoxate, Oxybenzone, Avobenzene, Octocrylene
Dosage form LOTION
Route TOPICAL
Labeler Genesis Pharmaceutical
Application part352
Marketing category OTC MONOGRAPH FINAL
Marketing start 2012-06-12
Marketing end 0000-00-00
Substance OCTINOXATE; OXYBENZONE; AVOBENZONE; OCTOCRYLENE
Active strength 27 mL/355mL; mL/355mL; mL/355mL; mL/355mL
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 38 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 64760-408-02 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 64760-408-02 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 64760-408-02 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 64760-408-02 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 64760-408-02 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 64760-408-02 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 64760-408-02 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 64760-408-02 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 64760-408-02 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 64760-408-02 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 64760-408-02 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 64760-408-02 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 64760-408-02 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 64760-408-02 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 64760-408-02 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 64760-408-02 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 64760-408-02 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 64760-408-02 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product I Inactivated by FDA 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 64760-408-02 I Inactivated by FDA 110d247fa046…a55b01930146…
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded AVOBENZONE ACTIVE INGREDIENT G63QQF2NOX GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 OCTINOXATE ACTIVE INGREDIENT 4Y5P7MUD51 GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 OCTOCRYLENE ACTIVE INGREDIENT 5A68WGF6WM GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 OXYBENZONE ACTIVE INGREDIENT 95OOS7VE0Y GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 AVOBENZONE ACTIVE MOIETY G63QQF2NOX GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 OCTINOXATE ACTIVE MOIETY 4Y5P7MUD51 GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 OCTOCRYLENE ACTIVE MOIETY 5A68WGF6WM GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 OXYBENZONE ACTIVE MOIETY 95OOS7VE0Y GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 .ALPHA.-TOCOPHEROL ACETATE INACTIVE INGREDIENT 9E8X80D2L0 GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 ALKYL (C12-15) BENZOATE INACTIVE INGREDIENT A9EJ3J61HQ GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 C13-14 ISOPARAFFIN INACTIVE INGREDIENT E4F12ROE70 GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 CETEARYL GLUCOSIDE INACTIVE INGREDIENT 09FUA47KNA GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 CETOSTEARYL ALCOHOL INACTIVE INGREDIENT 2DMT128M1S GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 CETYL ALCOHOL INACTIVE INGREDIENT 936JST6JCN GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 CHOLESTEROL INACTIVE INGREDIENT 97C5T2UQ7J GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 CYCLOMETHICONE 4 INACTIVE INGREDIENT CZ227117JE GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 CYCLOMETHICONE 5 INACTIVE INGREDIENT 0THT5PCI0R GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 DIMETHICONOL (250000 MW) INACTIVE INGREDIENT RKI3S914RT GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 EDETATE DISODIUM INACTIVE INGREDIENT 7FLD91C86K GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 GLYCERYL MONOSTEARATE INACTIVE INGREDIENT 230OU9XXE4 GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 GLYCOLIC ACID INACTIVE INGREDIENT 0WT12SX38S GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 LAURETH-7 INACTIVE INGREDIENT Z95S6G8201 GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 PEG-100 STEARATE INACTIVE INGREDIENT YD01N1999R GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 PEG-150 STEARATE INACTIVE INGREDIENT 7BSG7DF10Q GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 PHENOXYETHANOL INACTIVE INGREDIENT HIE492ZZ3T GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 POLYACRYLAMIDE (10000 MW) INACTIVE INGREDIENT E2KR9C9V2I GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 SHEA BUTTER INACTIVE INGREDIENT K49155WL9Y GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 WATER INACTIVE INGREDIENT 059QF0KO0R GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1 XANTHAN GUM INACTIVE INGREDIENT TTV12P4NEE GLYTONE BODY (OCTINOXATE, OXYBENZONE, AVOBENZENE, OCTOCRYLENE) LOTION [GENESIS PHARMACEUTICAL] 1